Vireo Growth (VREOF) Prepaid Assets (2020 - 2026)
Vireo Growth (VREOF) posted Prepaid Assets of $6.5 million for Q1 2026, up 71.05% sequentially from $3.8 million in Q4 2025, and up 1124.31% YoY from $530912.0 in Q1 2025.
Vireo Growth (VREOF) Prepaid Assets (2020 - 2026) Analysis & Trends
Vireo Growth has reported Prepaid Assets for 7 years, with the latest figure at $6.5 million in Q1 2026.
- Quarterly Prepaid Assets rose 1124.31% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (up 1124.31% YoY) and the FY2025 annual result came in at $3.8 million, up 130.17% from the prior year.
- Prepaid Assets grew to $6.5 million in Q1 2026 per VREOF's latest filing, from $3.8 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.5 million in Q1 2026 and troughed at $414732.0 in Q2 2024.
- A 5-year average of $2.2 million and a median of $1.7 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2026: Prepaid Assets plunged 74.51% in 2023, then surged 1124.31% in 2026.
- Over 5 years, Prepaid Assets stood at $2.5 million in 2022, then slumped by 47.49% to $1.3 million in 2023, then advanced by 23.55% to $1.7 million in 2024, then surged by 130.17% to $3.8 million in 2025, then surged by 71.05% to $6.5 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $6.5 million, $3.8 million, and $5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Vireo Growth | 487.39 Mn | 345.09 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.50 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 530,912.00 |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 414,732.00 |
| Mar 31, 2024 | 641,365.00 |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.01 Mn |
| Mar 31, 2023 | 634,462.00 |
| Dec 31, 2022 | 2.54 Mn |
| Sep 30, 2022 | 748,973.00 |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | 838,612.00 |
| Sep 30, 2021 | 1.64 Mn |
| Jun 30, 2021 | 714,531.00 |